Ashok Aarthi, Hegde Ramanujan S
Cell Biology and Metabolism Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, United States of America.
PLoS Pathog. 2009 Jun;5(6):e1000479. doi: 10.1371/journal.ppat.1000479. Epub 2009 Jun 19.
Prion diseases are fatal neurodegenerative disorders caused by aberrant metabolism of the cellular prion protein (PrP(C)). In genetic forms of these diseases, mutations in the globular C-terminal domain are hypothesized to favor the spontaneous generation of misfolded PrP conformers (including the transmissible PrP(Sc) form) that trigger downstream pathways leading to neuronal death. A mechanistic understanding of these diseases therefore requires knowledge of the quality control pathways that recognize and degrade aberrant PrPs. Here, we present comparative analyses of the biosynthesis, trafficking, and metabolism of a panel of genetic disease-causing prion protein mutants in the C-terminal domain. Using quantitative imaging and biochemistry, we identify a misfolded subpopulation of each mutant PrP characterized by relative detergent insolubility, inaccessibility to the cell surface, and incomplete glycan modifications. The misfolded populations of mutant PrPs were neither recognized by ER quality control pathways nor routed to ER-associated degradation despite demonstrable misfolding in the ER. Instead, mutant PrPs trafficked to the Golgi, from where the misfolded subpopulation was selectively trafficked for degradation in acidic compartments. Surprisingly, selective re-routing was dependent not only on a mutant globular domain, but on an additional lysine-based motif in the highly conserved unstructured N-terminus. These results define a specific trafficking and degradation pathway shared by many disease-causing PrP mutants. As the acidic lysosomal environment has been implicated in facilitating the conversion of PrP(C) to PrP(Sc), our identification of a mutant-selective trafficking pathway to this compartment may provide a cell biological basis for spontaneous generation of PrP(Sc) in familial prion disease.
朊病毒疾病是由细胞朊蛋白(PrP(C))异常代谢引起的致命性神经退行性疾病。在这些疾病的遗传形式中,球状C末端结构域的突变被认为有利于错误折叠的朊蛋白构象异构体(包括可传播的PrP(Sc)形式)的自发产生,这些构象异构体触发导致神经元死亡的下游途径。因此,对这些疾病的机制理解需要了解识别和降解异常朊蛋白的质量控制途径。在这里,我们对一组C末端结构域中导致遗传疾病的朊蛋白突变体的生物合成、运输和代谢进行了比较分析。通过定量成像和生物化学方法,我们鉴定出每个突变型PrP的一个错误折叠亚群,其特征是相对不溶于去污剂、无法接近细胞表面以及聚糖修饰不完全。尽管在ER中可证明存在错误折叠,但突变型PrP的错误折叠群体既未被ER质量控制途径识别,也未被导向ER相关降解。相反,突变型PrP运输到高尔基体,从那里错误折叠的亚群被选择性地运输到酸性区室进行降解。令人惊讶的是,选择性重新路由不仅取决于突变的球状结构域,还取决于高度保守的无结构N末端中一个额外的基于赖氨酸的基序。这些结果定义了许多致病PrP突变体共有的特定运输和降解途径。由于酸性溶酶体环境与促进PrP(C)向PrP(Sc)的转化有关,我们对该区室的突变体选择性运输途径的鉴定可能为家族性朊病毒疾病中PrP(Sc)的自发产生提供细胞生物学基础。